FuturHealth Launches Affirm to Offer a Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness Solutions Published 6:00 am Tuesday, March 25, 2025 SAN DIEGO, March 25, 2025 /PRNewswire/ FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth
Key Features Research Use Only (RUO) compound formulation Contains BPC-157, KPV, and GHK-Cu 60 capsules per bottle Encapsulated format for ease of handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Composition (per capsule): BPC-157 500 mcg KPV 500 mcg GHK-Cu 1 mg Form: Capsules Bottle Size: 60 capsules Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes
Governments will increasingly demand favorable cost-benefit evidence, may cap prices, may restrict access, or enforce demonstration of long-term safety more rigorously
Before-and-after claims, as often seen on social media, should also be viewed critically
Interestingly, altered -oxidation followed by inhibition of CPTIA remarkably attenuate c-mycmediated lymphomagenesis, implying a potential role CPTI had in the pathogenesis of c-mycdriven cancer